Cutting Copays Act

Bill 118 s 3951, also known as the Cutting Copays Act, is a piece of legislation introduced in the US Congress. The main goal of this bill is to reduce the out-of-pocket costs that individuals have to pay for prescription drugs.

The bill specifically targets copayments, which are the fixed amounts that individuals are required to pay for their medications. These copayments can add up quickly, especially for individuals who require multiple medications or have chronic conditions.

The Cutting Copays Act aims to lower these costs by capping copayments for prescription drugs at $35 per month for individuals with private insurance. This cap would apply to both brand-name and generic medications, providing relief for those who struggle to afford their necessary medications. In addition to capping copayments, the bill also includes provisions to increase transparency around drug pricing and to prevent pharmaceutical companies from engaging in anti-competitive practices that drive up costs for consumers. Overall, the Cutting Copays Act is designed to make prescription drugs more affordable for Americans and to ensure that individuals can access the medications they need without facing financial hardship.